(Q50883754)

English

Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. (English)

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

Timmer A

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Sutherland LR

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Martin F

3

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Gastroenterology

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

114

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

6

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

1143-1150

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease. a retrospective cohort study of 71 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Predicting relapses of Crohn's disease. Clouds in the crystal ball

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Evolving concepts of psychopathology in inflammatory bowel disease. Implications for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Do life events or depression exacerbate inflammatory bowel disease? A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effect of cigarette smoking on recurrence of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Smoking in Crohn's disease: effect on localisation and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effects of cigarette smoking on the long-term course of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effect of cigarette smoking on the course of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Cigarette smoking and risk of clinical relapse in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effect of oral contraceptive use on reoperation following surgery for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Multivariate survival analysis using Cox's regression model

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Analysis of biological variables in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Crohn's disease: risk of recurrence and reoperation in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Cigarette smoking and intestinal defences

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effect of cigarette smoking on Langerhans' cells

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Smoking and intestinal absorption of oral polyethylene glycols in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Effect of ulcerative colitis and smoking on rectal blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Smoking, the oral contraceptive pill, and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Early mucosal changes in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Increased risk of inflammatory bowel disease associated with oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Oral contraceptive use and cigarette smoking in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Colonic Crohn's disease and use of oral contraception.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Risk indicators for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Oral Contraceptive Use and the Risk of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

Smoking habits and recurrence in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for an increased risk of Crohn's disease in oral contraceptive users

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The problem of postoperative recurrence of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970419-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0016-5085(98)70419-6

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/9618650

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50883754&oldid=1387535088"